Compare Diageo plc (DEO) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diageo plc vs UnitedHealth Group Inc — how do they compare? Diageo plc trades at $86.83 (market cap $47.67B), while UnitedHealth Group Inc trades at $379.5 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 7× Diageo plc's market cap, and UnitedHealth Group Inc pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold Diageo plc for 66 Days and UnitedHealth Group Inc for 97 Days on average.
| DEO | UNH | |
|---|---|---|
Market Cap | $47.67B | $332.96B |
Volume | 893,372 | 7,273,749 |
Sector | Consumer Staples | Health |
52-Week High | $102.14 | $436.35 |
52-Week Low | $72.47 | $259.02 |
Typical Hold Time | 66 Days | 97 Days |
Enterprise Value | $68.09B | $374.82B |
Dividend Yield | 2.3% | 2.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Diageo (DEO) trades at $86.73, up 2.36% with bullish technical signals from moving averages. The company shows strong profitability with 59.47% gross margins and has beaten earnings estimates in the last three quarters. Recent developments include a new CFO appointment and marketing initiatives across key brands. The stock faces headwinds from declining 2026 revenue projections but maintains solid cash flow generation.
DEO presents a mixed outlook with analyst consensus leaning bullish (49% buy ratings) but facing execution risks in its US turnaround. The stock's premium valuation (P/E 27.9) requires sustained earnings growth, while regulatory challenges in India and competitive pressures warrant monitoring. Near-term catalysts include dividend payments and brand revitalization efforts.
UnitedHealth Group (UNH) trades at $375.98, showing minor daily weakness but maintaining a bullish technical signal. The company reported strong Q2 2026 earnings, beating estimates, and reaffirmed its full-year outlook. Revenue growth remains robust, though net margins have compressed from prior years. Analyst sentiment is overwhelmingly positive, with a consensus price target of $473.89 implying significant upside.
The outlook for UNH is favorable, driven by earnings momentum and strategic initiatives like AI investment. Key risks include regulatory pressures and medical cost trends. The stock presents a compelling opportunity for investors seeking exposure to a leading healthcare company with solid fundamentals and Wall Street support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
